Daniel Zaheer
Lawyer
A co-founder of the Kobre & Kim IP team described as a “powerhouse” by Intellectual Asset Magazine, Daniel Zaheer has advised clients in matters ranking among the highest value patent infringement, trade secret, and intellectual property disputes. Mr. Zaheer has obtained victories totaling more than US $1.5 billion on behalf of clients, including the second largest existing trade secret judgment in US history. He has been recognized time and again as a leading trial litigator, oral advocate, and strategist in the field, having been named a “Top Trade Secrets Lawyer” and “Top IP Lawyer” by the Daily Journal, "Litigator of the Week" by The American Lawyer, and “Client Choice Winner” by Lexology.
Mr. Zaheer’s practice centers on enforcing intellectual property rights and defending against charges of infringement in a variety of industries, including artificial intelligence, wireless communication systems, renewable fuels, biotechnology and mobile applications. He has obtained some of the most significant intellectual property results of the last decade, having secured multiple nine-figure recoveries on behalf of his clients in patent enforcement campaigns and trade secrets cases. In representation of defendants, Mr. Zaheer has obtained reversal of nine- and ten-figure decisions in multiple actions involving allegations of trade secrets theft as well as in other complex commercial disputes.
Prior to joining Kobre & Kim, Mr. Zaheer practiced at Kerr & Wagstaffe LLP. Earlier in his career, Mr. Zaheer served as a law clerk to the Honorable Charles R. Breyer of the U.S. District Court for the Northern District of California and the Honorable Raymond C. Fisher of the U.S. Court of Appeals for the Ninth Circuit. Mr. Zaheer also served as deputy city attorney for the City and County of San Francisco and practiced at Quinn Emanuel Urquhart Oliver & Hedges LLP.
Mr. Zaheer’s cases of note include:
* Propel Fuels v. Phillips 66 Co. – On behalf of renewable fuels pioneer Propel Fuels, obtained a $604.9 million jury verdict for trade secret misappropriation as co-lead trial counsel and then obtained an additional $195 million in court-awarded exemplary damages as lead oral advocate and brief writer. Zaheer then obtained a ruling from the trial court denying all of Phillips 66’s post-trial motions, thereby securing a final total judgment of $833 million (including then-accrued interest).
* CSIRO Wi-Fi Litigation – On behalf of the Australian government’s national science organization, obtained more than $400 million in payments after a series of litigations enforcing CSIRO’s patent covering the core technology underlying wi-fi. The overall campaign has been recognized as among the most successful single-patent enforcement efforts.
* AI v. Krisp Technologies, Inc. – In ongoing litigation on behalf of leading voice AI innovator Sanas.AI, obtained a ruling from the trial court rejecting a section 101 Alice eligibility challenge to all five challenged Sanas patents—a rare win for AI companies seeking to protect their IP against such assaults.
* Botulinum Neurotoxin ITC Litigation – In a blockbuster dispute called the “Botox War,” obtained ITC ruling rejecting complainant’s central trade secret claim.
* CSIRO Omega-3 Patent Litigation – As lead trial counsel for CSIRO, obtained jury verdict that client’s genetic engineering patents were valid and infringed, and rejecting the defendants’ assertion that client misused their proprietary information.
Mr. Zaheer’s practice centers on enforcing intellectual property rights and defending against charges of infringement in a variety of industries, including artificial intelligence, wireless communication systems, renewable fuels, biotechnology and mobile applications. He has obtained some of the most significant intellectual property results of the last decade, having secured multiple nine-figure recoveries on behalf of his clients in patent enforcement campaigns and trade secrets cases. In representation of defendants, Mr. Zaheer has obtained reversal of nine- and ten-figure decisions in multiple actions involving allegations of trade secrets theft as well as in other complex commercial disputes.
Prior to joining Kobre & Kim, Mr. Zaheer practiced at Kerr & Wagstaffe LLP. Earlier in his career, Mr. Zaheer served as a law clerk to the Honorable Charles R. Breyer of the U.S. District Court for the Northern District of California and the Honorable Raymond C. Fisher of the U.S. Court of Appeals for the Ninth Circuit. Mr. Zaheer also served as deputy city attorney for the City and County of San Francisco and practiced at Quinn Emanuel Urquhart Oliver & Hedges LLP.
Mr. Zaheer’s cases of note include:
* Propel Fuels v. Phillips 66 Co. – On behalf of renewable fuels pioneer Propel Fuels, obtained a $604.9 million jury verdict for trade secret misappropriation as co-lead trial counsel and then obtained an additional $195 million in court-awarded exemplary damages as lead oral advocate and brief writer. Zaheer then obtained a ruling from the trial court denying all of Phillips 66’s post-trial motions, thereby securing a final total judgment of $833 million (including then-accrued interest).
* CSIRO Wi-Fi Litigation – On behalf of the Australian government’s national science organization, obtained more than $400 million in payments after a series of litigations enforcing CSIRO’s patent covering the core technology underlying wi-fi. The overall campaign has been recognized as among the most successful single-patent enforcement efforts.
* AI v. Krisp Technologies, Inc. – In ongoing litigation on behalf of leading voice AI innovator Sanas.AI, obtained a ruling from the trial court rejecting a section 101 Alice eligibility challenge to all five challenged Sanas patents—a rare win for AI companies seeking to protect their IP against such assaults.
* Botulinum Neurotoxin ITC Litigation – In a blockbuster dispute called the “Botox War,” obtained ITC ruling rejecting complainant’s central trade secret claim.
* CSIRO Omega-3 Patent Litigation – As lead trial counsel for CSIRO, obtained jury verdict that client’s genetic engineering patents were valid and infringed, and rejecting the defendants’ assertion that client misused their proprietary information.
Languages
- English